Benjamin Suttle
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
Papers in
-
- Melanoma and MAPK Pathways 3
- Renal and related cancers 2
- Oncology 9
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Peter Ho (3 shared papers)Vincent Ribrag (4 shared papers)Jean‐Marie Michot (4 shared papers)Antoîne Italiano (2 shared papers)Maud Toulmonde (2 shared papers)Carlo Lucchesi (1 shared paper)Alicia Clawson (1 shared paper)Heike Keilhack (1 shared paper)
- Journals
- Journal of Clinical Oncology (11 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Blood (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Benjamin Suttle
20 papers receiving 770 citations
Benjamin Suttle's Hit Papers
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 159
- Oncology 228
- Cancer Research 110
- Genetics 75
- Molecular Biology 496
Countries citing papers authored by Benjamin Suttle
This map shows the geographic impact of Benjamin Suttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Suttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Suttle more than expected).
Fields of papers citing papers by Benjamin Suttle
This network shows the impact of papers produced by Benjamin Suttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Suttle. The network helps show where Benjamin Suttle may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Suttle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study Hit paper breakdown → | 2018 | 469 |
| 2 | 2005 | 66 | |
| 3 | 2020 | 56 | |
| 4 | 2014 | 46 | |
| 5 | 2010 | 23 | |
| 6 | 2014 | 23 | |
| 7 | 2015 | 22 | |
| 8 | 2011 | 16 | |
| 9 | 1995 | 14 | |
| 10 | 2012 | 8 | |
| 11 | 2008 | 7 | |
| 12 | 2007 | 6 | |
| 13 | 2011 | 6 | |
| 14 | 2014 | 5 | |
| 15 | 2014 | 4 | |
| 16 | A STUDY OF THE EFFECTS OF INHIBITION OF CYP3A4 BY KETOCONAZOLE (K) AND CYP2C8 BY GEMFIBROZIL (G) ON THE PHARMACOKINETICS DABRAFENIB (D) | 2014 | 3 |
| 17 | 2018 | 3 | |
| 18 | 2003 | 2 | |
| 19 | 2016 | 2 | |
| 20 | A Multi-Targeted Receptor Tyrosine Kinase Inhibitor for the Treatment of Neovascular AMD: Results of a Healthy Volunteer Safety and Tolerability Study of Pazopanib Eye Drops | 2009 | 2 |
About Benjamin Suttle
Benjamin Suttle is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 21 papers that have together received 783 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (4 papers), Renal cell carcinoma treatment (4 papers), Cancer Treatment and Pharmacology (4 papers), Melanoma and MAPK Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers), Renal and related cancers (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (159 citations), Oncology (228 citations), Cancer Research (110 citations), Genetics (75 citations) and Molecular Biology (496 citations). Benjamin Suttle has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Peter Ho, Vincent Ribrag, Jean‐Marie Michot, Antoîne Italiano, Maud Toulmonde, Carlo Lucchesi, Alicia Clawson, Heike Keilhack, Stephen J. Blakemore and Mark Woodruff. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Clinical Pharmacology & Therapeutics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.